ALC:NYSE
Alcon AG
66,99 US$
arrow_downward
-1,34%(-0,91) 1D
10 qer, 10:47:16 p.d., GMT-4 · USD
search
Të gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALC...
Hap
67,03 US$
I lartë
67,30 US$
I ulët
66,43 US$
Kapitalizimi i tregut
26,69 mld
Vëllimi mesatar
2,50 mln
Vëllimi
275,75 mijë
Maksimumi 52-javor
92,55 US$
Minimumi 52-javor
61,84 US$
Beta
0,88
Aksionet në qarkullim
491,20 mln
Numri i punonjësve
25 mijë
Hap
67,03 US$
I lartë
67,30 US$
I ulët
66,43 US$
Kapitalizimi i tregut
26,69 mld
Vëllimi mesatar
2,50 mln
Vëllimi
275,75 mijë
Maksimumi 52-javor
92,55 US$
Minimumi 52-javor
61,84 US$
Beta
0,88
Aksionet në qarkullim
491,20 mln
Numri i punonjësve
25 mijë
Lajmet
Nga burimet nëpër ueb
AD HOC NEWS
·
19 orë më parë
Alcon Inc stock (CH0432492467): eye-care specialist steadies after Q1 earnings and dividend update
AD HOC NEWS
·
22 orë më parë
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after recent earnings and outlook
Profili
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Rreth Alcon AG
Drejtori ekzekutivDavid J. Endicott
Punonjësit25 mijë
Themeluar më1945
SeliaGjeneva, Kantoni Gjenevë, Zvicër
SektoriMedical device
Uebsajtialcon.com
Përmbajtjet me IA mund të përfshijnë gabime. Mëso më shumë